Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4105 Target Snapshot

5-hydroxytryptamine receptor 1D · SINGLE PROTEIN · Sus scrofa

154Compounds
17Assays
2Approved Drugs
176.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P79400. Use UniProt P79400 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P79400 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 1D as ChEMBL target CHEMBL4105, mapped to UniProt P79400. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 1D
SINGLE PROTEIN · Sus scrofa
As of 2026-09-14
ChEMBL target ID
CHEMBL4105
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P79400
5-hydroxytryptamine receptor 1D
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 1D is the right protein anchor across sources, using UniProt P79400 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 1D
UniProt AccessionP79400
Component TypeProtein
Sequence Length291 aa

5-hydroxytryptamine receptor 1D

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 1D, mapped to UniProt P79400. Sequence length is 291 aa.

Mapped IDP79400
Review name5-hydroxytryptamine receptor 1D
OrganismSus scrofa
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50173.0
KI3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL39435 9.6 IC50 0.2512 Preclinical
CHEMBL39317 9.5 IC50 0.3162 Preclinical
CHEMBL289489 9.3 IC50 0.5012 Preclinical
CHEMBL288880 9.1 IC50 0.7943 Preclinical
CHEMBL39331 9.1 IC50 0.7943 Preclinical
CHEMBL262652 8.9 IC50 1.259 Preclinical
CHEMBL40126 8.9 IC50 1.259 Preclinical
CHEMBL37629 8.8 IC50 1.585 Preclinical
CHEMBL37462 8.7 IC50 1.995 Preclinical
CHEMBL38104 8.7 IC50 1.995 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
4
5.5
10
6.0
8
6.5
21
7.0
25
7.5
15
8.0
8
8.5
3
9.0
3
9.5
pChEMBL
Approved Drugs

Approved Drugs

RIZATRIPTAN
CHEMBL905
Approved 1998
SUMATRIPTAN
CHEMBL128
Approved 1992
Assay Landscape

Assay Landscape

17
Total Assays
128
Tested Compounds
2
Assay Types
Binding — 16 assays, 128 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 6 37 7.3
single protein format 5 49 5.2
cell membrane format 4 40 8.2
tissue-based format 1 2 5.1
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine